The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
After leading AstraZeneca's Oncology areas nationally and internationally, Laura Colón will assume the presidency of AstraZeneca in one of its priority global markets
The new assets expand Biocon Biologics’ already robust oncology portfolio, which now includes 17 cancer therapies
The investigational subcutaneous hepcidin mimetic peptide is designed to regulate iron and red blood cell production
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
Cidara will become a wholly owned subsidiary of Merck and the common stock of Cidara will no longer be listed or traded on the Nasdaq Global Market
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Subscribe To Our Newsletter & Stay Updated
